Glyca levels during the earliest stages of rheumatoid arthritis: potential use as a biomarker of subclinical cardiovascular disease
Fecha de publicación:
2020
Versión del editor:
Citación:
Journal of Clinical Medicine, 9(8) (2020); doi:10.3390/jcm9082472
DOI:
Patrocinado por:
This work was supported by European Union FEDER funds, Fondo de Investigación Sanitaria (PI16/00113; ISCIII, Spain) and Plan de Ciencia, Tecnología e Innovación FICYT 2018–2020 del Principado de Asturias (IDI/2018/000152). J.R.-C. was supported by postdoctoral contract from the Juan de la Cierva program (IJCI-2017-32070; Ministry of Science, Innovation and Universities, Spain), Sara Borrell program (CD19/00120; from ISCIII), and the ISPA Intramural Program (ISPA Emergentes JRC; from ISPA).
Colecciones
- Artículos [36139]
- Biología Funcional [754]
- Investigaciones y Documentos OpenAIRE [7870]